Article

Influence of the COMT Genotype on Working Memory and Brain Activity Changes During Development

Biological psychiatry (impact factor: 8.93). 04/2011; 70(3). DOI:10.1016/j.biopsych.2011.02.027

ABSTRACT Background: The Valine158Methionine (Val158Met) polymorphism of the COMT gene leads to lower enzymatic activity and higher dopamine availability in Met carriers. The Met allele is associated with better performance and reduced prefrontal cortex activation during working memory (WM) tasks in adults. Dopaminergic system changes during adolescence may lead to a reduction of basal dopamine levels, potentially affecting Met allele benefits during development. Methods: We investigated the association of COMT genotype with behavioral (n 322) and magnetic resonance imaging data (n 81– 84) collected during performance of a visuospatial WM task and potential changes in these effects during development (reflected in age genotype interactions). Data were collected from a cross-sectional and longitudinal typically developing sample of 6-to 20-year-olds. Results: Visuospatial WM capacity exhibited an age genotype interaction, with a benefit of the Met allele emerging after 10 years of age. There was a parallel age genotype interaction on WM-related activation in the right inferior frontal gyrus and intraparietal sulcus (IPS), with increases in activation with age in the Val/Val group only. Main effects of COMT genotype were also observed in the IPS, with greater gray matter volumes bilaterally and greater right IPS activation in the Val/Val group compared with the Met carriers.

0 0
 · 
0 Bookmarks
 · 
37 Views
  • Article: Intermediate phenotypes and genetic mechanisms of psychiatric disorders.
    [show abstract] [hide abstract]
    ABSTRACT: Genes are major contributors to many psychiatric diseases, but their mechanisms of action have long seemed elusive. The intermediate phenotype concept represents a strategy for characterizing the neural systems affected by risk gene variants to elucidate quantitative, mechanistic aspects of brain function implicated in psychiatric disease. Using imaging genetics as an example, we illustrate recent advances, challenges and implications of linking genes to structural and functional variation in brain systems related to cognition and emotion.
    Nature reviews. Neuroscience 11/2006; 7(10):818-27. · 30.44 Impact Factor
  • Article: The dopamine hypothesis of schizophrenia: version III--the final common pathway.
    [show abstract] [hide abstract]
    ABSTRACT: The dopamine hypothesis of schizophrenia has been one of the most enduring ideas in psychiatry. Initially, the emphasis was on a role of hyperdopaminergia in the etiology of schizophrenia (version I), but it was subsequently reconceptualized to specify subcortical hyperdopaminergia with prefrontal hypodopaminergia (version II). However, these hypotheses focused too narrowly on dopamine itself, conflated psychosis and schizophrenia, and predated advances in the genetics, molecular biology, and imaging research in schizophrenia. Since version II, there have been over 6700 articles about dopamine and schizophrenia. We selectively review these data to provide an overview of the 5 critical streams of new evidence: neurochemical imaging studies, genetic evidence, findings on environmental risk factors, research into the extended phenotype, and animal studies. We synthesize this evidence into a new dopamine hypothesis of schizophrenia-version III: the final common pathway. This hypothesis seeks to be comprehensive in providing a framework that links risk factors, including pregnancy and obstetric complications, stress and trauma, drug use, and genes, to increased presynaptic striatal dopaminergic function. It explains how a complex array of pathological, positron emission tomography, magnetic resonance imaging, and other findings, such as frontotemporal structural and functional abnormalities and cognitive impairments, may converge neurochemically to cause psychosis through aberrant salience and lead to a diagnosis of schizophrenia. The hypothesis has one major implication for treatment approaches. Current treatments are acting downstream of the critical neurotransmitter abnormality. Future drug development and research into etiopathogenesis should focus on identifying and manipulating the upstream factors that converge on the dopaminergic funnel point.
    Schizophrenia Bulletin 04/2009; 35(3):549-62. · 8.80 Impact Factor
  • Source
    Article: Developmental changes in multivariate neuroanatomical patterns that predict risk for psychosis in 22q11.2 deletion syndrome.
    [show abstract] [hide abstract]
    ABSTRACT: The primary objective of the current prospective study was to examine developmental patterns of voxel-by-voxel gray and white matter volumes (GMV, WMV, respectively) that would predict psychosis in adolescents with 22q11.2 deletion syndrome (22q11.2DS), the most common known genetic risk factor for schizophrenia. We performed a longitudinal voxel-based morphometry analysis using structural T1 MRI scans from 19 individuals with 22q11.2DS and 18 typically developing individuals. In 22q11.2DS, univariate analysis showed that greater reduction in left dorsal prefrontal cortical (dPFC) GMV over time predicted greater psychotic symptoms at Time2. This dPFC region also showed significantly reduced volumes in 22q11.2DS compared to typically developing individuals at Time1 and 2, greater reduction over time in 22q11.2DS COMT(Met) compared to COMT(Val), and greater reduction in those with greater decline in verbal IQ over time. Leave-one-out Multivariate pattern analysis results (MVPA) on the other hand, showed that patterns of GM and WM morphometric changes over time in regions including but not limited to the dPFC predicted risk for psychotic symptoms (94.7-100% accuracy) significantly better than using univariate analysis (63.1%). Additional predictive brain regions included medial PFC and dorsal cingulum. This longitudinal prospective study shows novel evidence of morphometric spatial patterns predicting the development of psychotic symptoms in 22q11.2DS, and further elucidates the abnormal maturational processes in 22q11.2DS. The use of neuroimaging using MVPA may hold promise to predict outcome in a variety of neuropsychiatric disorders.
    Journal of psychiatric research 03/2011; 45(3):322-31. · 3.72 Impact Factor

Full-text (2 Sources)

View
7 Downloads
Available from
26 Oct 2012

Keywords

age genotype interaction
 
age genotype interactions
 
basal dopamine levels
 
COMT genotype
 
Dopaminergic system changes
 
greater gray matter volumes bilaterally
 
inferior frontal gyrus
 
intraparietal sulcus
 
lower enzymatic activity
 
magnetic resonance imaging data
 
Met allele
 
Met allele benefits
 
Met carriers
 
parallel age genotype interaction
 
potential changes
 
prefrontal cortex activation
 
Val/Val group
 
Valine158Methionine
 
visuospatial WM task
 
WM-related activation